Aragen, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the appointment of Neeraj Garg as CEO of its Discovery Solutions business. In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base, improving operational efficiencies, and incubating new capabilities to accelerate partners’ research […]
Post Type Archives: News
Sterling Pharma Solutions Welcomes Karl Rotthier as new Chief Executive Officer
Karl Rotthier commences his tenure as Chief Executive Officer of Sterling Pharma Solutions Kevin Cook will retire at end of October 2025 Sterling Pharma Solutions announced the appointment of Karl Rotthier as Chief Executive Officer (CEO), effective 21 October, 2025. Karl Rotthier succeeds Kevin Cook, who has served as CEO since 2013 and has now […]
Merck to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio
Merck, a leading science and technology company, today announced the signing of a definitive agreement to acquire the chromatography business of JSR Life Sciences, a leader in contract development and manufacturing, preclinical and translational clinical research, and bioprocessing solutions. The acquisition will expand Merck’s downstream processing portfolio with advanced Protein A chromatography capabilities, supporting more […]
Syngene International invests in dedicated peptide laboratory and advanced automation
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced site upgrades to accelerate drug discovery and development, helping clients bring novel therapies to market faster. The investments included a dedicated, state-of-the-art peptide laboratory in Bengaluru and the integration of advanced automation […]
Almac Trial Coordinator Launched in $48 Million Investment to Advance Integrated eClinical Technologies
Innovative technology platform reshapes how sponsors, CRO, and clinical sites manage complex clinical trials at scale Almac Group announced a $48 million investment in eClinical technologies that includes the launch of Almac Trial Coordinator™ – a first-in-class interoperable clinical trial technology platform, enhancements to its eClinical ecosystem capabilities, and creation of over 100 advanced technology […]
Codis Launches as Global CDMO for Commercial Spray Drying and Amorphous Solid Dispersions
Codis officially launches as a new global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions (ASD), and particle engineering technologies. Formed through the integration of Particle Dynamics in the US and the Haverhill, UK spray drying facility previously operated by EUROAPI, Codis combines decades of regulatory expertise and manufacturing strength under one brand. With […]
Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept
Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organization (CRO), today announced a strategic partnership to deliver fully integrated early phase clinical trial solutions. The partnership will combine Quotient Sciences’ expertise in early clinical development with Biorasi’s global patient recruitment capabilities to provide biotech and pharma […]
Ensera launches as new brand identity for SteriPack
SteriPack, a global contract design and manufacturing organization (CDMO) for the pharmaceutical and medical device industries, has announced its trading name change to Ensera, signaling a strategic shift in its identity and service offering. Ensera represents the company’s evolution into a global partner providing industry-leading expertise in medical device design and manufacturing, and final assembly […]
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood
Andernach– LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company announced the acquisition of Renaissance Lakewood, LLC (“Renaissance”), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms. With the acquisition, Renaissance facilities will become part of the worldwide operations network of LTS, along with LTS’ existing […]
Adva Biotechnology and Autolomous Launch the Digital PIONEER Program to Enable Decentralized, Scalable Cell Therapy Manufacturing — GenCART Inc. Joins as First Clinical Participant
Adva Biotechnology Ltd. and Autolomous Ltd. today announced the launch of the Digital PIONEER Program, a joint initiative aimed at digitising, decentralising, and scaling out autologous cell therapy manufacturing. GenCART Inc., a promising clinical-stage biotechnology company, has joined as the first clinical partner, bringing its therapeutic expertise to help validate the integrated platform through real-world application. The Digital PIONEER […]